These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6800004)

  • 1. [Electrophysiologic and hemodynamic effects of disopyramide phosphate (author's transl)].
    Suzuki S; Kasanuki H; Onishi S; Tanaka T; Hirosawa K; Tanaka T; Abe M; Kohashi K; Taniguchi T; Matsuda M
    Kokyu To Junkan; 1981 Oct; 29(10):1079-84. PubMed ID: 6800004
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P
    Therapie; 1981; 36(2):179-86. PubMed ID: 7292392
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulatory effects of intravenous disopyramide in heart failure.
    Jensen G; Uhrenholt A
    J Int Med Res; 1976; 4(1 Suppl):42-5. PubMed ID: 1026527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effects of disopyramide and lidocaine on negative inotropic action--evaluation by multigated RI angiography (author's transl)].
    Kito Y; Fujita T; Kosakai Y; Naito Y; Koyanagi H; Ohara K; Ego Y; Hayashi K; Manabe H; Nishimura T; Kozuka T
    Kokyu To Junkan; 1981 Apr; 29(4):405-10. PubMed ID: 7255990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction].
    Bassan R; Miqueloti P; de Souza MA; Luz FS
    Arq Bras Cardiol; 1982 Nov; 39(5):355-7. PubMed ID: 7186390
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
    Kötter V; Linderer T; Schröder R
    Am J Cardiol; 1980 Sep; 46(3):469-75. PubMed ID: 7415992
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
    Stauch M; Grewe N; Nissen H
    MMW Munch Med Wochenschr; 1976 Mar; 118(11):331-4. PubMed ID: 57570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic and hemodynamic effects of diltiazem].
    Umemura J; Kasanuki H; Ohnishi S; Tanaka E; Hagiwara N; Hagiwara Y; Nirei T; Hirosawa K
    Kokyu To Junkan; 1986 Mar; 34(3):303-7. PubMed ID: 3704374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of disopyramide on cardiovascular dynamics in man].
    Aquaro G; Poletti T; Pavia M; D'Arrigo A
    Boll Soc Ital Cardiol; 1971; 16(9):587-90. PubMed ID: 4948542
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiological and clinical effects of disopyramide in atrial arrhythmic disease in the initial stage].
    Arlotti M; Ambrosini F; Musacchio E; Manfredini R; Duca GP; Lotto A
    Clin Ter; 1988 Jul; 126(1):27-33. PubMed ID: 2973955
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of Bay a 1040 before and after atropine administration].
    Lydtin H; Lohmöller R
    Verh Dtsch Ges Inn Med; 1972; 78():1554-9. PubMed ID: 4665607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.